Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$2.77 - $5.0 $839 - $1,515
303 Added 2.74%
11,357 $36,000
Q4 2021

Jan 20, 2022

BUY
$8.93 - $14.85 $98,712 - $164,151
11,054 New
11,054 $99,000

Others Institutions Holding SQZ

About SQZ Biotechnologies Co


  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Bangor Savings Bank Portfolio

Follow Bangor Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bangor Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bangor Savings Bank with notifications on news.